scholarly journals Exam 1: Risk of Serious Infections With Vedolizumab Versus Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease

2022 ◽  
Vol 20 (2) ◽  
pp. e337-e338
Keyword(s):  
Inflammatory Bowel Disease ◽  
Tumor Necrosis Factor ◽  
Bowel Disease ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Antagonists ◽  
Serious Infections ◽  
Inflammatory Bowel ◽  
Necrosis Factor

scholarly journals Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease

JAMA ◽  
2017 ◽  
Vol 318 (17) ◽  
pp. 1679 ◽  
Author(s):  
Magali Lemaitre ◽  
Julien Kirchgesner ◽  
Annie Rudnichi ◽  
Fabrice Carrat ◽  
Mahmoud Zureik ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Tumor Necrosis Factor ◽  
Bowel Disease ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Antagonists ◽  
Inflammatory Bowel ◽  
Necrosis Factor

Systematic Review of Tumor Necrosis Factor Antagonists in Extraintestinal Manifestations in Inflammatory Bowel Disease

2017 ◽  
Vol 15 (1) ◽  
pp. 25-36.e27 ◽  
Author(s):  
Laurent Peyrin-Biroulet ◽  
Gert Van Assche ◽  
David Gómez-Ulloa ◽  
Laura García-Álvarez ◽  
Núria Lara ◽  
...  
Keyword(s):  
Systematic Review ◽  
Inflammatory Bowel Disease ◽  
Tumor Necrosis Factor ◽  
Bowel Disease ◽  
Tumor Necrosis ◽  
Extraintestinal Manifestations ◽  
Tumor Necrosis Factor Antagonists ◽  
Inflammatory Bowel ◽  
Necrosis Factor
Sign in / Sign up

Export Citation Format

Share Document